With the advent of the new era of tumor immunotherapy and the accessibility of drugs, the treatment of uroepithelial cancer is developing rapidly, bringing more choices and benefits to patients. In order to explore the clinical unmet therapeutic needs, share numerous academic achievements in the translation of basic clinical results and various cross-disciplinary hot topics, exchange clinical and research experiences, and solve the clinical practice problems, the UC Whole Course of Treatment Academic Conference Series, which is sponsored by Chengdu High-Tech Medical Association and co-sponsored by West China Hospital of Sichuan University, focuses on the young and middle-aged doctors, and pays attention to the latest academic frontiers of the treatment of uroepithelial carcinoma in the international and domestic arena. Hot issues will be discussed, and clinical practice problems will be exchanged to bring more new ideas for the treatment of uroepithelial cancer in China.

At that time, Chengdu Hi-Tech Medical Association will host and West China Hospital of Sichuan University will co-sponsor the 2024 “Bladder Expedition Bo Yin” series of academic conferences on UC treatment, inviting experts and scholars in related fields to conduct in-depth exchanges and discussions on the hot issues related to the treatment of uroepithelial carcinoma, in order to promote the enhancement of the academic level of the field of UC treatment.